Company had operating loss before financial costs and income tax of 971 million Baht (89% of total revenues). The operating loss increased by 38% as compared to the same period last year of a loss of 704
the financial management agreement according to the repayment period. Income tax payable decreased by 25.3 MB, representing a decrease of 67.5% due to during in Q3–2021, the 2020 tax payment and the
., Nongeiroon, Banbueng, Chonburi, Thailand 20220 Tel. 038-160707 Fax. 033-047348 www.ndrubber.co.th No. NDR003/2019 22 February 2019 Subject: Management Discussion and Analysis (MD&A) Report for the Year 2018
-TRANSLATION- 25 February 2019 Subject : Management Discussion and Analysis for 2018 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in
., Nongeiroon, Banbueng, Chonburi, Thailand 20220 Tel. 038-160707 Fax. 033-047348 www.ndrubber.co.th No. NDR003/2019 22 February 2019 Subject: Management Discussion and Analysis (MD&A) Report for the Year 2018
Public Company Limited 1 | P a g e November 13, 2019 Subject: Management discussion and analysis of the operating results for the quarter 3/2019 Attn: President The Stock Exchange of Thailand Please find
DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 1 of 3 No. DOD026/2563 February 26, 2020 Subject Management Discussion and Analysis of for
stated ) Q1 2017 Q1 2016 Change Amount % Total Revenues 3,946 3,910 36 0.9% Sales and service income 3,829 3,818 8 0.2% Other income 117 92 25 27.9% Cost of sales and services 3,533 3,550 (17) -0.5% SG&A
สรุปผลการดำเนินงานของบจ -Translation- August 15th, 2017 Subject: Management Discussion and Analysis Quarter 3 Ending 30 Jun 2017 (Edited Template) To: Managing Director The Stock Exchange of Thailand
1 Translation CEN 025-2017 November 13, 2017 Subject : Management Discussion and Analysis for business operation of quarter 3/2017 To The Manager and President The Stock Exchange of Thailand For 3